Clinical Formulary · MP-TIR-V-45
Tirzepatide 45mg / 3ml — Dual Agonist Vial
Dual GIP/GLP-1 agonist vial — advanced metabolic support for clinical weight programs.
Active
Tirzepatide 45mg total
Volume
3ml multi-dose vial
Mechanism
GIP/GLP-1 dual agonist
SKU: MP-TIR-V-45
Order This Product
Dual GIP/GLP-1 agonist vial — advanced metabolic support for clinical weight programs.
Key Benefits
- Dual GIP + GLP-1 receptor agonist
- 45mg / 3ml clinical vial
- Metabolic & weight management support
- Structured titration per clinic protocol
Tirzepatide is a dual GIP and GLP-1 receptor agonist offering a complementary pathway for weight management and glycemic support. This 45mg / 3ml vial supports clinic programs requiring dual incretin pathway activation under physician oversight.
$250.00
Professional clinical use only. Terms & conditions apply.
Product Solution Guide
Clinical Use & Administration
Weight management and metabolic health programs in clinical settings. Used as part of a comprehensive protocol including diet, activity, and medical supervision.
Follow your clinic's approved protocol. Steps below are general guidance for qualified practitioners.
- 1
Verify & Prepare
Confirm patient identity, prescription, and vial integrity. Gather sterile syringes, alcohol swabs, and sharps container. Wash hands and use aseptic technique.
- 2
Draw Dose
Using a sterile syringe, draw the physician-prescribed dose from the vial. Expel air bubbles and verify volume at eye level before administration.
- 3
Subcutaneous Injection
Administer subcutaneously into the abdomen, thigh, or upper arm. Rotate injection sites weekly to reduce irritation. Do not inject intravenously or intramuscularly unless protocol specifies.
- 4
Document & Store
Record lot number, dose, site, and date in patient chart. Recap vial and refrigerate immediately after use. Discard per clinic biohazard policy if compromised.
Clinic Ordering Notes
Bulk and multi-vial clinic orders available. Contact Professional Services for protocol kits and wholesale pricing.